Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06161077 · ClinicalTrials.gov registry record
Voice Quality Analysis of Patients With Laryngotracheal Stenosis
A clinical trial, sponsored by Johns Hopkins University.
- Not yet
- Registry status
- 100
- Enrollment target
NCT06161077: Clinical Trial study, sponsored by Johns Hopkins University.
NCT06161077 is a clinical trial that has not yet begun recruiting, run by Johns Hopkins University. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06161077 has not yet begun recruiting, sponsored by Johns Hopkins University.
- NOT YET RECRUITING
- Registry status
- 100 participants
- Enrollment target
Study Summary
The investigators previously demonstrated that voice changes are common in patients with Laryngotracheal Stenosis (LTS), and patients typically report an improvement in voice outcomes following endoscopic dilation. Recently, NIH based programs such as a Bridge to Artificial Intelligence (Bridge2AI) have highlighted the use of artificial intelligence to identify acoustic biomarkers of disease. Therefore, the investigators hypothesize that progression of LTS scar can be quantified using acoustic measurements and machine learning. The goal of this clinical trial is to remotely monitor patient voice quality in an effort to determine if regularly performed voice recordings can be used as a diagnostic tool in order to predict the need for dilation procedures. The investigators feel that successful use of remote voice recording technology with algorithmic analysis will improve patient quality of life.
Interventions
- DIAGNOSTIC_TEST Voice Biomarker Screening Too
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2028-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06161077
The ClinicalTrials.gov registry entry for NCT06161077 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Voice Biomarker Screening Too is the first listed.
NCT06161077 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06161077 about?
NCT06161077 is a clinical study titled "Voice Quality Analysis of Patients With Laryngotracheal Stenosis". The investigators previously demonstrated that voice changes are common in patients with Laryngotracheal Stenosis (LTS), and patients typically report an improvement in voice outcomes following endoscopic dilation. Recently, NIH based programs such as a Bridge to Artificial Intelligence (Bridge2AI) ...
What is the current status of trial NCT06161077?
This trial is currently not yet recruiting. The enrollment target is 100 participants. The study started on 2026-07-01. Estimated completion is 2028-12-01.
What interventions are being tested in trial NCT06161077?
The interventions under investigation include: Voice Biomarker Screening Too (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06161077?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.